🔎 Trials Near Me

Akèy › Nefrit Lupus › Illinois

Etid klinik pou Nefrit Lupus nan Illinois

9 etid pou Nefrit Lupus ap chèche patisipan nan sit nan Illinois.

Vil nan Illinois

Tèks ofisyèl etid la (Anglè)

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

  • University of Chicago, Chicago
Ap rekriteFaz 2
Laj 16 a 70 · Tout sèks · Mizajou Sep 17, 2026 · NCT07328581

VIBRANT: VIB4920 for Active Lupus Nephritis

  • University of Chicago, Department of Medicine: Rheumatology, Chicago
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05201469

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • University of Chicago Medicine- Comer Children's, Chicago
Ap rekriteFaz 2
Laj 8 a 20 · Tout sèks · Mizajou Sep 14, 2026 · NCT05538208

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

  • Research Site, Chicago
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Sep 10, 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • The University of Chicago Medical Center, Chicago
Ap rekriteFaz 1
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

  • Nkarta Investigational Site, Chicago
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Jun 4, 2026 · NCT06557265

Lupus Landmark Study: A Prospective Registry and Biorepository

  • University of Chicago, Chicago
Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.